Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GF Xinde Investment Management

Investor type Investment Bank


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 96
Average round size
The average size of a deal this fund participated in
Portfolio companies 85
Rounds per year 6.40
Lead investments 16
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 20
Key employees 1

Areas of investment

  • Manufacturing
  • E-Commerce
  • Information Technology
  • Hardware
  • Health Care

GF Xinde Investment Management appeared to be the VC, which was created in 2008. The main department of described VC is located in the Guangzhou. The company was established in Asia in China.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Energy, Service Industry. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline JMGO, Global Scanner, Energy Monster

We also calculated 1 valuable employee in our database.

Opposing the other organizations, this GF Xinde Investment Management works on 21 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. When the investment is from GF Xinde Investment Management the average startup value is 100-500 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the GF Xinde Investment Management, startups are often financed by GSR Ventures, ZhenFund, IDG Capital. The meaningful sponsors for the fund in investment in the same round are Shunwei Capital, ZhenFund, Ping An Ventures. In the next rounds fund is usually obtained by Shunwei Capital, Xiaomi, Sinowisdom.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GF Xinde Investment Management:
Typical Co-investors
GF Xinde Investment Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GF Xinde Investment Management:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

GenScript ProBio

$220M18 Jan 2023 Nanjing, Jiangsu, China


Medical Device
$15M10 Jan 2023 Changzhou, Zhejiang, China


Health Care
Medical Device
09 Jan 2023 Changzhou, Zhejiang, China


Medical Device
28 Dec 2022 Nanjing, Jiangsu, China

Hengchuang Nano

27 Dec 2022 Yancheng, Jiangsu, China

Sinian Smart Driving

$15M14 Nov 2022 Beijing, Beijing, China

Black Sesame Technologies

Artificial Intelligence
Machine Learning
08 Aug 2022 San Jose, California, United States


3D Printing
3D Technology
Paper Manufacturing
17 Jun 2022 Shenzhen, Guangdong, China

Accro Bioscience

$50M04 Jan 2022 Suzhou, Jiangsu, China
Tavotek Biotherapeutics Snares $20M in Series A

– Tavotek Biotherapeutics from Lower Gwynedd, Pennsylvania, has raised over $20M in financing in the preceding two months.
YuanBio Venture Capital led the A1 finance round followed by Oriza Holdings, Ming BioVentures, and New Alliance Capital.
– Series A2 financing was jointly invested by GF Xinde, CTS Capital, and Lanhu Capital.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GF Xinde Investment Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: